Johnson & Johnson Financial Report: Key Insights & Debt Overview

Here are the key insights extracted from the provided section of the financial report:

1. Entity Information:

• Name: Johnson & Johnson (referred to as JNJ).
• CIK Number: 0000200406.
• Location: One Johnson & Johnson Plaza, New Brunswick, NJ 08933.
• Contact: Phone number is 732-524-0400.
• Exchange: Common stock is traded on NYSE under the symbol "JNJ".
• Par Value of Common Stock: $1.00.

2. Debt Instruments:

• The entity has multiple debt instruments with varying maturity dates and interest rates:
• • 1.150% Notes Due November 2028 (Ticker: JNJ28)
  • 3.200% Notes Due June 2032 (Ticker: JNJ32)
  • 1.650% Notes Due May 2035 (Ticker: JNJ35)
  • 3.350% Notes Due June 2036 (Ticker: JNJ36A)
  • 3.550% Notes Due June 2044 (Ticker: JNJ44)

3. Reporting Context:

• The report covers a specific date context: February 26, 2025, indicating that the information is relevant to that particular date.

4. Structure and Compliance:

• The report is structured according to the US Generally Accepted Accounting Principles (US GAAP) and uses the XBRL (eXtensible Business Reporting Language) format for regulatory compliance.
• The report includes explicit members indicating different classes of stock and specific notes due in the future.

5. Overall Financial Position:

• The presence of multiple debt instruments suggests that Johnson & Johnson is utilizing debt financing, which may indicate ongoing investment or operational needs.

This summary provides a snapshot of the corporate structure, debt obligations, and compliance context, which can be critical for analyzing the financial health and strategic direction of Johnson & Johnson.